ADORA2A and hepatocellular carcinoma: Through the correlation analysis of immune checkpoint-related genes, it was found that most of the immune checkpoint-related genes were positively correlated with the high-risk and low-risk groups of HCC patients, and only the ADORA2A gene was negatively correlated with the risk of HCC patients (Figure 5A,B, p < 0.05).